Royalties on Sales Clause Samples

Royalties on Sales. KRONOGEN SCIENCES will pay to Giampapa royalties as follows: (i) KRONOGEN SCIENCES shall pay Giampapa a royalty of 6% of the Net Sales Price of Units sold by KRONOGEN SCIENCES that are developed by Giampapa for KRONOGEN SCIENCES ("Royalties"). (ii) Royalties shall be due and payable to Giampapa based on each Unit actually sold by KRONOGEN SCIENCES, less any returns and allowances. No Royalty will be due and payable on any Units shipped as promotional product where KRONOGEN SCIENCES does not receive any payment; KRONOGEN SCIENCES will endeavor to use good business judgment in regard to these Units, it being acknowledged that the parties' intention in connection therewith is to generate additional sales of Units and/or goodwill. (iii) Royalties due and payable hereunder shall be paid on a quarterly basis within 45 days after the close of each calendar quarter and, shall be accompanied by a written statement setting forth sales information in respect of Units sold during such quarter. (iv) Giampapa or his authorized certified public accountant shall have the right to examine the books, accounts and records of KRONOGEN SCIENCES, from time to time up to two times per year, at mutually agreed upon times and dates, to ensure that the Royalty statements are complete, current and accurate in all material respects and that any Royalties due hereunder have been paid to Giampapa as required by this License Agreement.

Royalties on Sales. In consideration of the right granted by SANOFI-AVENTIS to IDM to market IL-13 Products and IL-13 Research Kits, IDM shall pay SANOFI-AVENTIS a royalty equal to [...***...] of the Net Sales volume acheived by IDM in connection with this marketing. Net Sales acheived by SANOFI-AVENTIS as an IDM licensee in application of the 2001 Agreement shall not be included in the Net Sales base. IDM shall maintain a special set of books, with the corresponding supporting documentation, including all elements necessary for calculating the amount payable by IDM to SANOFI-AVENTIS pursuant to the provisions above. SANOFI-AVENTIS may cause these books to be verified, at its simple request made with sufficient advance notice, by an independent expert chosen jointly by the Parties and, absent an agreement within fifteen (15) days of the date on which SANOFI-AVENTIS has requested the audit, by the Presiding Judge of the Lower Court of Paris on the petition of the first-acting Party. The expert shall use his best efforts to notify his findings within a period of thirty (30) days after referral of the case. The findings of this expert shall be final and without recourse. The expert’s fees and costs will be paid by SANOFI-AVENTIS except if the total amount owed by IDM to SANOFI-AVENTIS is more than five per cent (5%) greater than the amount reported by IDM, in which case these costs and fees shall be paid by IDM.”

Royalties on Sales. The LICENSEE shall pay to SKYC for the Licensed Rights a royalty equal to five percent (5%) of LICENSEE's net sales, as defined in Section

Royalties on Sales. Biovail shall pay to the Licensors or to their assigns, in accordance with the provisions of paragraph 8.10 below, a royalty in the amount of {***}† of the Net Sales of each Royalty Bearing Product in the Territory as well as of any material value or reduction that Biovail may obtain from the purchasers of the Product in compensation for the Product and of any payment or settlement for disputes with third parties over the use or purchase of the Product.

Royalties on Sales. 4.7.1 As an offset for the costs incurred by FBFC during the 5 year development of the PRODUCTS, ORTHOVITA shall pay FBFC running royalties on the SALES as from the earlier of : (i) the date of delivery on a cumulative basis of 1.000 doses of 0.75 gram of BIOACTIVE GLASS GRANULES pursuant to Article 2.4.; and (ii) the expiration date of the period referred to in Article 2.

Royalties on Sales. Licensee shall pay to Licensor patent royalty payments of (i) ********** of the Gross Revenue for Royalty-based Licensed Products sold or leased by Licensee or any Affiliate or Sublicensee for use in non-utility vehicles during the License Period and (ii) ********** of the Gross Revenue for Royalty-based Licensed Products sold or leased by Licensee or any Affiliate or Sublicensee for use in any other application. Notwithstanding the foregoing, Licensee’s royalty payments under this Section 5.2 shall be offset by any royalty payment amount for the same Licensed Products made under the Non-Exclusive License Agreement. Such payments shall be made concurrently with the reports required pursuant to Section 6.2 and shall be directed in equal shares to USC and Caltech at their respective addresses set forth in Section 15.6, or to such other account or address as may be directed by USC or Caltech, as the case may be, in a notice pursuant to Section 15.6 sent to Licensee.